PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 223 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,493,000 | +227.4% | 83,001 | +29.7% | 0.01% | +200.0% |
| Q1 2020 | $456,000 | -82.9% | 63,972 | -42.7% | 0.00% | -83.3% |
| Q4 2019 | $2,664,000 | +635.9% | 111,560 | +726.4% | 0.02% | +500.0% |
| Q3 2019 | $362,000 | +64.5% | 13,500 | +66.7% | 0.00% | +200.0% |
| Q2 2019 | $220,000 | -82.7% | 8,100 | -77.9% | 0.00% | -90.0% |
| Q1 2019 | $1,271,000 | -58.8% | 36,631 | -76.8% | 0.01% | -54.5% |
| Q4 2018 | $3,085,000 | +38.8% | 157,990 | +89.4% | 0.02% | +83.3% |
| Q3 2018 | $2,222,000 | +296.8% | 83,432 | +462.7% | 0.01% | +300.0% |
| Q2 2018 | $560,000 | +34.9% | 14,827 | +100.6% | 0.00% | 0.0% |
| Q2 2017 | $415,000 | +484.5% | 7,390 | +310.6% | 0.00% | – |
| Q1 2017 | $71,000 | +39.2% | 1,800 | -28.0% | 0.00% | – |
| Q1 2016 | $51,000 | +292.3% | 2,500 | +733.3% | 0.00% | – |
| Q3 2015 | $13,000 | +160.0% | 300 | +200.0% | 0.00% | – |
| Q2 2015 | $5,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 270,832 | $6,467,000 | 5.27% |
| Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
| Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
| First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
| Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
| Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
| HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |